Table 2 Descriptive statistics: patients with and without IR supplementation at 90 days^a

Patients with IR supplementation at 90 days

Time in Treatment Prior to ER (Days)

23

0.08

4761.07

746.11

1109.78

Baseline

 ASSET

23

0.98

5.44

3.76

1.21

 PHQ-9

23

0

24

6.43

5.88

 GAD-2

23

0.00

6.0

1.57

1.59

 CGI-S

21

2

5

3.67

0.66

 CGI-I

20

1

4

2.10

0.79

90 days

 ASSET

23

0.97

5.02

3.00

0.98

 PHQ-9

23

0

23

5.61

5.37

 GAD-2

23

0.00

6.00

1.91

2.11

 CGI-S

21

3

4

3.57

0.51

CGI-I

20

1

4

2.15

0.67

Valid N (listwise)

17

Patients without IR supplementation at 90 days

Time in Treatment Prior to ER (Days)

393

0.021435

4745.88

989.10

1164.93

Baseline

 ASSET

385

0.00

5.98

3.50

1.19

 PHQ-9

392

0

21

7.08

4.68

 GAD-2

393

0.00

6.00

1.93

1.55

 CGI-S

371

2

6

3.83

0.76

 CGI-I

360

1

6

2.81

1.13

90 days

 ASSET

385

0.00

5.88

3.12

1.08

 PHQ-9

392

0

24

5.65

4.36

 GAD-2

393

0.00

6.00

1.68

1.47

 CGI-S

371

1

6

3.71

0.82

 CGI-I

360

1

5

2.57

0.97

Valid N (listwise)

313